$18.85 1.6%
CSTL Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Castle Biosciences

Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions.

Castle Biosciences
Price $18.85
Target Price Sign up
Volume 402,890
Market Cap $512M
Year Range $17.13 - $25.3
Dividend Yield 0%
Revenue per Employee $520,133
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2473M14M59M-2.5M-230,000-0.090
Q4 '2366M12M54M-2.6M-130,000-0.100
Q3 '2361M11M50M-6.9M-4.6M-0.260
Q2 '2350M11M39M-19M-17M-0.700
Q1 '2342M10M32M-29M-27M-1.100

Insider Transactions View All

Oelschlager Kristen M filed to sell 148,618 shares at $21.2.
July 3 '24
MAETZOLD DEREK J filed to sell 8,525 shares at $24.
June 5 '24
MAETZOLD DEREK J filed to sell 71,379 shares at $24.
June 5 '24
MAETZOLD DEREK J filed to sell 57,893 shares at $24.
June 5 '24
MAETZOLD DEREK J filed to sell 8,531 shares at $23.4.
June 5 '24

What is the Market Cap of Castle Biosciences?

The Market Cap of Castle Biosciences is $512M.

How Many People Work at Castle Biosciences?

As of our latest update, Castle Biosciences employed approximately 482 people worldwide. However, it's important to note that Castle Biosciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Castle Biosciences' revenue per employee?

$520,133. To calculate Castle Biosciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Castle Biosciences?

Currently, the price of one share of Castle Biosciences stock is $18.85.

How can I analyze the CSTL stock price chart for investment decisions?

The CSTL stock price chart above provides a comprehensive visual representation of Castle Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Castle Biosciences shares. Our platform offers an up-to-date CSTL stock price chart, along with technical data analysis and alternative data insights.

Does CSTL offer dividends to its shareholders?

As of our latest update, Castle Biosciences (CSTL) does not offer dividends to its shareholders. Investors interested in Castle Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Castle Biosciences?

Some of the similar stocks of Castle Biosciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.